Clinical and Economic Impact of Differential COVID-19 Vaccine Effectiveness in the United States

Michael Maschio, Kelly Fust, Amy Lee, Nicolas Van de Velde, Philip O. Buck, Michele A. Kohli
doi: https://doi.org/10.1101/2022.03.31.22272957

Article Information

doi 
https://doi.org/10.1101/2022.03.31.22272957
History 
  • April 3, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Michael Maschio, MSc1,
  2. Kelly Fust, MSc1,
  3. Amy Lee, PhD1,
  4. Nicolas Van de Velde, PhD2,
  5. Philip O. Buck, PhD2 and
  6. Michele A. Kohli, PhD1,*
  1. 1Quadrant Health Economics Inc; 92 Cottonwood Crescent, Cambridge, Ontario, Canada
  2. 2Moderna Inc; 200 Technology Square, Cambridge, MA, United States
  1. ↵*Correspondence:
    Michele Kohli, Quadrant Health Economics Inc.; 92 Cottonwood Crescent, Cambridge, Ontario, Canada; michele.kohli{at}quadrantHE.com
Back to top
Posted April 03, 2022.
Download PDF
Data/Code
Email
Clinical and Economic Impact of Differential COVID-19 Vaccine Effectiveness in the United States
Michael Maschio, Kelly Fust, Amy Lee, Nicolas Van de Velde, Philip O. Buck, Michele A. Kohli
medRxiv 2022.03.31.22272957; doi: https://doi.org/10.1101/2022.03.31.22272957
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area